Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding Esperion Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of ESPR: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders2014207+10
Shares151.3M15.0M174.9M+38.6M (+28.3%)
Value$559.6M$55.4M$479.3M−$25.0M (−5.0%)

4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (41)

Institutions that held Esperion Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to ESPR in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC10,433,760$28.6M0.00%
Armistice Capital, LLC3,930,125$10.8M0.36%
Vanguard Portfolio Management LLC3,532,563$9.68M0.00%
Privium Fund Management B.V.3,299,441$9.04M1.88%
Point72 Asset Management, L.P.1,689,372$4.63M0.01%
Vanguard Fiduciary Trust Co1,564,234$4.29M0.00%
Rhenman & Partners Asset Management AB985,000$2.70M0.33%
Squarepoint Ops LLC700,153$1.92M0.00%
Jump Financial, LLC689,874$1.89M0.03%
Public Employees Retirement System of Ohio521,081$1.43M0.00%
Pavaki Capital Management LLC410,000$1.12M0.79%
Man Group plc339,775$931.0K0.00%
State of Wisconsin Investment Board260,029$712.5K0.00%
Gotham Asset Management, LLC208,451$571.2K0.00%
Qube Research & Technologies Ltd208,161$570.4K0.00%
Eleva Capital SAS183,047$501.5K0.15%
Engineers Gate Manager LP164,773$451.5K0.01%
Vanguard Global Advisers, LLC148,790$407.7K0.00%
Franklin Resources Inc126,374$346.3K0.00%
Canada Pension Plan Investment Board108,100$296.2K0.00%
Lido Advisors, LLC99,139$271.6K0.00%
Axq Capital, LP94,159$258.0K0.03%
Kingsbury Capital Investment Advisors LLC47,449$130.0K0.12%
Excelsior Advisor Network LLC45,000$123.3K0.05%
Simplex Trading, LLC36,467$99.9K0.00%
LMR Partners LLP35,859$98.3K0.00%
Two Sigma Securities, LLC27,909$76.5K0.01%
Oxford Asset Management LLP27,330$74.9K0.03%
ADAR1 Capital Management, LLC21,400$58.6K0.00%
Mesirow Financial Investment Management, Inc.20,000$54.8K0.00%
Mirabella Financial Services LLP18,858$51.7K0.01%
Options Solutions, LLC13,000$35.6K0.03%
CIBC Bancorp USA Inc.12,131$33.2K0.00%
Sanchez Gaunt Capital Management, LLC11,312$31.0K0.02%
Sanders Morris Harris LLC11,100$30.4K0.00%
CI Private Wealth, LLC11,821$13.8K0.00%
Advisory Services Network, LLC2,050$5.62K0.00%
Fifth Third Bancorp523$1.43K0.00%
Fortitude Family Office, LLC243$6660.00%
Bare Financial Services, Inc141$3860.00%
Root Financial Partners, LLC44$1210.00%

Sold out (31)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (4)

Institutions that held Esperion Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ESPR in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc14,945,454$55.3M
CIBC World Markets Corp15,477$57.3K
Pandora Wealth, Inc.7,500$27.8K
Comerica Bank15$56